Article
DNA Damage Repair Deficiency in Prostate Cancer.
Trends in cancer - 1 Nov 2020
Burdak-Rothkamm Susanne, Mansour Wael Y, Rothkamm Kai
Abstract excerpt
Molecular-targeted therapies and treatment stratification based on molecular biomarkers have rapidly gained momentum in the therapeutic spectrum for patients with prostate cancer, particularly those with aggressive disease. DNA damage repair (DDR) pathways are commonly impaired in prostate cancer. Recent studies have detailed mechanisms interconnecting the DDR with the androgen receptor (AR) signaling pathway as...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
